Literature DB >> 24366319

Bone. Regulating osteoclast differentiation to prevent bone loss.

Bryony Jones.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24366319     DOI： 10.1038/nrrheum.2013.206

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


× No keyword cloud information.
  1 in total

1.  The orally available Btk inhibitor ibrutinib (PCI-32765) protects against osteoclast-mediated bone loss.

Authors:  Masahiro Shinohara; Betty Y Chang; Joseph J Buggy; Yusuke Nagai; Tatsuhiko Kodama; Hiroshi Asahara; Hiroshi Takayanagi
Journal:  Bone       Date:  2013-12-04       Impact factor: 4.398
  1 in total
  1 in total

1.  TLR signaling that induces weak inflammatory response and SHIP1 enhances osteogenic functions.

Authors:  Manoj Muthukuru; Richard P Darveau
Journal:  Bone Res       Date:  2014-11-11       Impact factor: 13.567
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.